elivity®, Singapore’s science-first longevity supplement brand, has introduced NANOBOOST in Asia. Co-developed with a German biotech spin-off of Hamburg University, NANOBOOST is a patent-pending delivery technology built on advanced liposomal science, designed to support the efficient absorption of active compounds in their oral spray formats. It is the first technology of its class to reach consumers across Asia.
The technology is a further development of liposomal delivery. Liposomal delivery works by enclosing active compounds within a lipid-based shell that protects them as they move through the digestive environment. The shell’s composition mirrors the cell membrane, supporting compatibility with the body’s own biological structures.
NANOBOOST takes that principle further through precision homogenisation, a process that produces a range of ultra-fine delivery vehicles: liposomes, nanoemulsions, micelles, and hybrid systems. Each is engineered to carry and release active compounds through the body’s natural absorption mechanisms.
elivity® is expanding its portfolio with new formulations targeting mood, stress resilience, female and skin health. This range uses the patent-pending NANOBOOST oral spray delivery technology.
